Fischer-Rasokat Ulrich, Beyersdorf Friedhelm, Doenst Torsten
Department of Cardiovascular Surgery, Albert-Ludwigs-University of Freiburg, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany.
Basic Res Cardiol. 2003 Sep;98(5):329-36. doi: 10.1007/s00395-003-0414-y. Epub 2003 May 12.
Ischemic preconditioning (IPC) is considered the most potent mechanism to improve ischemia tolerance. We have demonstrated that insulin addition during reperfusion improves recovery of function in the isolated working rat heart. We herein compare the relative importance of these two mechanisms in improving recovery of postischemic function.
Isolated working rat hearts were perfused with Krebs-Henseleit buffer containing glucose (5 mmol/l) plus oleate (0.4 mmol/l) for 20 min and were then subjected to 15 min of ischemia followed by 35 min of reperfusion. IPC was achieved by an ischemic period of fi ve minutes followed by 10 minutes of reperfusion before ischemia. Insulin (1 mU/ml) was or was not added at the beginning of reperfusion. Wortmannin (WM, 3 micro mol/l), an inhibitor of phosphatidylinositol 3-kinase, was or was not present in the perfusate from the beginning of the experiments. We measured glucose uptake with [2-(3)H]glucose, cardiac power and tissue metabolite content at the end of the experiments.
Cardiac power before ischemia ranged from 7.17 to 10.4 mW. After ischemia, cardiac power recovered to 65.7 +/- 3.8% (Control). Insulin significantly improved recovery (96.3 +/- 10.8%, p < 0.05 vs. Control). This effect was also achieved by IPC (recovery 86.2 +/- 6.2%, p < 0.05). The effects of insulin and IPC were not additive (recovery 83.4 +/- 6.2%, p < 0.05). WM fully inhibited the effects of both insulin and IPC (69.5 +/- 3.3, 72.0 +/- 6.9, respectively). Basal glucose uptake ranged from 2.53 to 3.46 micro mol/gdry, and was significantly lower after ischemia in the presence of WM.
Insulin is a potent tool to improve postischemic contractile function. The improvement of recovery afforded by insulin added after ischemia may be mediated through a similar mechanism as ischemic preconditioning.
缺血预处理(IPC)被认为是提高缺血耐受性的最有效机制。我们已经证明,再灌注期间添加胰岛素可改善离体工作大鼠心脏的功能恢复。我们在此比较这两种机制在改善缺血后功能恢复中的相对重要性。
将离体工作大鼠心脏用含葡萄糖(5 mmol/L)加油酸(0.4 mmol/L)的 Krebs-Henseleit 缓冲液灌注 20 分钟,然后进行 15 分钟缺血,随后再灌注 35 分钟。通过在缺血前进行 5 分钟缺血期然后再灌注 10 分钟来实现 IPC。在再灌注开始时添加或不添加胰岛素(1 mU/ml)。从实验开始,灌注液中存在或不存在渥曼青霉素(WM,3 μmol/L),一种磷脂酰肌醇 3-激酶抑制剂。我们在实验结束时用[2-(3)H]葡萄糖测量葡萄糖摄取、心脏功率和组织代谢物含量。
缺血前心脏功率范围为 7.17 至 10.4 mW。缺血后,心脏功率恢复至 65.7±3.8%(对照组)。胰岛素显著改善了恢复情况(96.3±10.8%,与对照组相比 p<0.05)。IPC 也实现了这种效果(恢复率 86.2±6.2%,p<0.05)。胰岛素和 IPC 的作用不是相加的(恢复率 83.4±6.2%,p<0.05)。WM 完全抑制了胰岛素和 IPC 的作用(分别为 69.5±3.3、72.0±6.9)。基础葡萄糖摄取范围为 2.53 至 3.46 μmol/g 干重,在存在 WM 的情况下缺血后显著降低。
胰岛素是改善缺血后收缩功能的有效工具。缺血后添加胰岛素所带来的恢复改善可能是通过与缺血预处理类似的机制介导的。